156 related articles for article (PubMed ID: 34633053)
1. KIF22 promotes bladder cancer progression by activating the expression of CDCA3.
Li K; Li S; Tang S; Zhang M; Ma Z; Wang Q; Chen F
Int J Mol Med; 2021 Dec; 48(6):. PubMed ID: 34633053
[TBL] [Abstract][Full Text] [Related]
2. KIF4A promotes the development of bladder cancer by transcriptionally activating the expression of CDCA3.
Zheng P; Wu K; Gao Z; Li H; Li W; Wang X; Shi Z; Xiao F; Wang K; Li Z; Han Q
Int J Mol Med; 2021 Jun; 47(6):. PubMed ID: 33846765
[TBL] [Abstract][Full Text] [Related]
3. Kinesin family member 3A stimulates cell proliferation, migration, and invasion of bladder cancer cells in vitro and in vivo.
Zhou Q; Yu J; Zheng Q; Wu T; Ji Z; Zhuo Y
FEBS Open Bio; 2021 May; 11(5):1487-1496. PubMed ID: 31774623
[TBL] [Abstract][Full Text] [Related]
4. Suppression of KIF22 Inhibits Cell Proliferation and Xenograft Tumor Growth in Tongue Squamous Cell Carcinoma.
Liu Y; Li RH; Ren G; Jiang J
Biomed Res Int; 2020; 2020():6387545. PubMed ID: 32090103
[TBL] [Abstract][Full Text] [Related]
5. Suppression of KIF22 Inhibits Cell Proliferation and Xenograft Tumor Growth in Colon Cancer.
Li B; Zhu FC; Yu SX; Liu SJ; Li BY
Cancer Biother Radiopharm; 2020 Feb; 35(1):50-57. PubMed ID: 31657617
[No Abstract] [Full Text] [Related]
6. Inhibition of KIF22 suppresses cancer cell proliferation by delaying mitotic exit through upregulating CDC25C expression.
Yu Y; Wang XY; Sun L; Wang YL; Wan YF; Li XQ; Feng YM
Carcinogenesis; 2014 Jun; 35(6):1416-25. PubMed ID: 24626146
[TBL] [Abstract][Full Text] [Related]
7. KIF22 promotes the proliferation and glycolysis of melanoma by activating EGFR/STAT3 signaling.
Zhong Z; Zhong H
Clinics (Sao Paulo); 2023; 78():100307. PubMed ID: 37944197
[TBL] [Abstract][Full Text] [Related]
8. Lamin B2 contributes to the proliferation of bladder cancer cells via activating the expression of cell division cycle‑associated protein 3.
Ji J; Li H; Chen J; Wang W
Int J Mol Med; 2022 Sep; 50(3):. PubMed ID: 35775376
[TBL] [Abstract][Full Text] [Related]
9. KIF22 Promotes Development of Pancreatic Cancer by Regulating the MEK/ERK/P21 Signaling Axis.
Zhang R; Ma L; Wei Y; Wei K; Song T; Du Z; Feng Z
Biomed Res Int; 2022; 2022():6000925. PubMed ID: 35578724
[TBL] [Abstract][Full Text] [Related]
10. Effect of KIF22 on promoting proliferation and migration of gastric cancer cells via MAPK-ERK pathways.
Yu ZY; Jiang XY; Zhao RR; Qin JJ; Luo CJ; Ren YX; Ren W; Ma ZJ; Jiao ZY
Chin Med J (Engl); 2020 Apr; 133(8):919-928. PubMed ID: 32187050
[TBL] [Abstract][Full Text] [Related]
11. KIF20A Affects the Prognosis of Bladder Cancer by Promoting the Proliferation and Metastasis of Bladder Cancer Cells.
Shen T; Yang L; Zhang Z; Yu J; Dai L; Gao M; Shang Z; Niu Y
Dis Markers; 2019; 2019():4863182. PubMed ID: 31093305
[TBL] [Abstract][Full Text] [Related]
12. High Expression of KIF22/Kinesin-Like DNA Binding Protein (Kid) as a Poor Prognostic Factor in Prostate Cancer Patients.
Zhang Z; Xie H; Zhu S; Chen X; Yu J; Shen T; Li X; Shang Z; Niu Y
Med Sci Monit; 2018 Nov; 24():8190-8197. PubMed ID: 30427826
[TBL] [Abstract][Full Text] [Related]
13. KIF22 coordinates CAR and EGFR dynamics to promote cancer cell proliferation.
Pike R; Ortiz-Zapater E; Lumicisi B; Santis G; Parsons M
Sci Signal; 2018 Jan; 11(515):. PubMed ID: 29382784
[TBL] [Abstract][Full Text] [Related]
14. CDCA3 is a potential prognostic marker that promotes cell proliferation in gastric cancer.
Zhang Y; Yin W; Cao W; Chen P; Bian L; Ni Q
Oncol Rep; 2019 Apr; 41(4):2471-2481. PubMed ID: 30816466
[TBL] [Abstract][Full Text] [Related]
15. QKI-6 inhibits bladder cancer malignant behaviours through down-regulating E2F3 and NF-κB signalling.
Shi F; Deng Z; Zhou Z; Jiang CY; Zhao RZ; Sun F; Cui D; Bei XY; Yang BY; Sun Q; Wang XJ; Wu Q; Xia SJ; Han BM
J Cell Mol Med; 2019 Oct; 23(10):6578-6594. PubMed ID: 31449345
[TBL] [Abstract][Full Text] [Related]
16. YAP/TEAD4-induced KIF4A contributes to the progression and worse prognosis of esophageal squamous cell carcinoma.
Li Y; Zhu X; Yang M; Wang Y; Li J; Fang J; Guo W; Ma S; Guan F
Mol Carcinog; 2021 Jul; 60(7):440-454. PubMed ID: 34003522
[TBL] [Abstract][Full Text] [Related]
17.
Wei W; Sun J; Zhang H; Xiao X; Huang C; Wang L; Zhong H; Jiang Y; Zhang X; Jiang G
Cancer Res; 2021 Dec; 81(24):6142-6156. PubMed ID: 34702726
[TBL] [Abstract][Full Text] [Related]
18. Kinesin family member 23 (KIF23) contributes to the progression of bladder cancer cells in vitro and in vivo.
Yao DW; Song Q; He XZ
Neoplasma; 2021 Mar; 68(2):298-306. PubMed ID: 33231086
[TBL] [Abstract][Full Text] [Related]
19. KIF5A Promotes Bladder Cancer Proliferation
Tian DW; Wu ZL; Jiang LM; Gao J; Wu CL; Hu HL
Dis Markers; 2019; 2019():4824902. PubMed ID: 31354888
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal stem cells-derived exosomal microRNA-139-5p restrains tumorigenesis in bladder cancer by targeting PRC1.
Jia Y; Ding X; Zhou L; Zhang L; Yang X
Oncogene; 2021 Jan; 40(2):246-261. PubMed ID: 33122828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
